Protocol · Musculoskeletal Health
Kashin-Beck Disease Supportive Care Protocol
Selenium and Glucosamine Sulfate are the core of this stack, with 6 supporting supplements. Each row gives the amount the protocol lists and the grade our evidence database holds for that supplement in Kashin-Beck Disease Supportive Care.
We are re-verifying the studies cited on protocol pages; only confirmed citations are shown.
The stack
8 supplements · none graded yet
| Grade | Supplement | Amount listed | Why it’s in the stack | Evidence on file |
|---|---|---|---|---|
| Primary stackThe core of this protocol | ||||
| Selenium | Amount listed: 100–200 mcg daily for prevention; may need higher during treatment phase | Deficiency is a major causative factor; supplementation can prevent disease and slow progression | Not graded yet | |
| Glucosamine Sulfate | Amount listed: 1,500 mg daily | Supports cartilage repair and reduces joint damage; may help with established disease
| Not graded yet | |
| Supporting stackListed as additions to the core | ||||
| Chondroitin Sulfate | Amount listed: 800–1,200 mg daily | Cartilage component that supports joint health; often combined with glucosamine | Not graded yet | |
| Vitamin E | Amount listed: 200–400 IU daily | Antioxidant that may protect cartilage from oxidative damage; often deficient in endemic areas | Not graded yet | |
| Iodine | Amount listed: 150–200 mcg daily | Deficiency may co-occur with selenium deficiency in endemic areas; supports thyroid function | Not graded yet | |
| Vitamin C | Amount listed: 500–1,000 mg daily | Antioxidant; supports collagen synthesis for cartilage repair | Not graded yet | |
| Collagen Peptides | Amount listed: 10 g hydrolyzed collagen daily | Provides building blocks for cartilage repair | Not graded yet | |
| Omega-3 Fatty Acids | Amount listed: 2–3 g EPA+DHA daily | Anti-inflammatory effects may help reduce joint inflammation and pain | Not graded yet | |
How this protocol works
In plain language
Kashin-Beck Disease (KBD) is a chronic, endemic bone and joint disorder found primarily in certain regions of China, Siberia, and North Korea. It causes cartilage degeneration and bone damage, leading to joint pain, stiffness, limited mobility, and growth abnormalities in children (shortened fingers and limbs). The disease typically begins in childhood and progresses with age. The exact cause involves multiple factors, but selenium deficiency is a major contributing factor, along with possible mycotoxins in grain and low iodine levels.
CRITICAL: KBD prevention focuses on addressing selenium deficiency through supplementation or improving food selenium content in endemic areas. Once cartilage damage has occurred, it may be irreversible. Treatment is supportive - managing pain and maintaining joint function. Severe cases may require surgical intervention (joint replacement in adults). Relocating children from endemic areas can prevent disease progression. These supplements address deficiencies and support joint health but cannot reverse established damage.
Selenium* supplementation is the primary intervention for KBD. Multiple large trials in endemic areas have shown that selenium supplementation can prevent new cases and slow progression in early disease. Selenium deficiency is strongly linked to KBD risk.
Glucosamine Sulfate* supports cartilage health and has shown benefit in KBD trials for reducing pain and improving joint function. It provides building blocks for cartilage repair.
Chondroitin Sulfate* is often combined with glucosamine for joint support.
Vitamin E* is an antioxidant that protects cartilage from oxidative damage. Deficiency may be common in endemic areas.
Iodine* deficiency often occurs alongside selenium deficiency in KBD-endemic regions and should be addressed.
Vitamin C* supports collagen synthesis needed for cartilage repair and provides antioxidant protection.
Collagen Peptides* provide the structural components for cartilage maintenance.
Omega-3 Fatty Acids* can help reduce joint inflammation and pain.
Expected timeline: Prevention with selenium: ongoing from childhood in endemic areas. For established disease, joint supplements may take 2-3 months to show benefit for symptoms. Structural cartilage damage is generally irreversible.